<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">  <id>e5364d3b-971c-4329-8e7d-c8d1e12aa57c</id>  <name>VTE Prophylaxis_Clinical Neurosurgery Adult</name>  <description>    <lifecycle_state>Initial</lifecycle_state>    <details>      <purpose/>      <use/>      <misuse/>    </details>    <other_details>      <item>        <key>MetaDataSet:Sample Set </key>        <value>Template metadata sample set </value>      </item>      <item>        <key>Acknowledgements</key>        <value/>      </item>      <item>        <key>Business Process Level</key>        <value/>      </item>      <item>        <key>Care setting</key>        <value/>      </item>      <item>        <key>Client group</key>        <value/>      </item>      <item>        <key>Clinical Record Element</key>        <value/>      </item>      <item>        <key>Copyright</key>        <value/>      </item>      <item>        <key>Issues</key>        <value/>      </item>      <item>        <key>Owner</key>        <value/>      </item>      <item>        <key>Sign off</key>        <value/>      </item>      <item>        <key>Speciality</key>        <value/>      </item>      <item>        <key>User roles</key>        <value/>      </item>    </other_details>  </description>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;&lt;em&gt;&amp;nbsp;VTE Prophylaxis_Clinical Neurosurgery Adult Order Panel&lt;/em&gt;&lt;/p&gt;</value>      </item>      <item>        <key>Technical.ﻩ Technical Traceability</key>        <value>{~AHSID~e5364d3b-971c-4329-8e7d-c8d1e12aa57c~NAME~VTE Prophylaxis_Clinical Neurosurgery Adult}</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Caprini Score&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;Clinical Decision Support&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;strong&gt;Recommendation:&lt;/strong&gt; Patients undergoing major surgery should receive prophylaxis at least during hospital stay and longer for those with additional risk factors.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Low Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Non-major surgery in patients less than 40 years old with no risk factors&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Moderate Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1)&amp;nbsp;&amp;nbsp;&amp;nbsp; Non-major surgery with additional risk factors, or:&lt;/p&gt;&lt;p&gt;2)&amp;nbsp;&amp;nbsp;&amp;nbsp; Age 40-60 years old&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;High Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1)&amp;nbsp;&amp;nbsp;&amp;nbsp; Age greater than 60 years old, or:&lt;/p&gt;&lt;p&gt;2)&amp;nbsp;&amp;nbsp;&amp;nbsp; 40-60 years old with additional risk factors&lt;/p&gt;&lt;p&gt;3)&amp;nbsp;&amp;nbsp;&amp;nbsp; Major surgery in patients aged less than 40 with multiple risk factors&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Very High&lt;/p&gt;&lt;p&gt;Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1)&amp;nbsp;&amp;nbsp;&amp;nbsp; Major surgery in patients with multiple risk factors or:&lt;/p&gt;&lt;p&gt;2)&amp;nbsp;&amp;nbsp;&amp;nbsp; Any patient having hip or knee arthroplasty, or:&lt;/p&gt;&lt;p&gt;3)&amp;nbsp;&amp;nbsp;&amp;nbsp; Major trauma or spinal cord injury.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;Major Risk Factors: Major surgery, trauma, ischemic stroke or paralysis, spinal cord injury, previous VTE, congenital and/or acquired thrombophilia states, or active cancer and its treatment, active COVID-19 infection&lt;br&gt;&amp;nbsp;&lt;br&gt;Minor Risk Factors: Age greater than 40 years, estrogen therapy, nephrotic syndrome, pregnancy/postpartum, prolonged immobility greater than 24 hours, general anesthesia longer than 1 hour, severe respiratory disease, collagen vascular disease, inflammatory bowel disease, congestive heart failure, obesity, sepsis, varicose veins&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Contraindications:&lt;/strong&gt;&lt;br&gt;Uncontrolled hypertension, Bleeding disorders (platelets less than 50 x 109/L), Recent intracranial or intraocular hemorrhage, Lumbar puncture within 24 hours, Active bleeding, Heparin-induced thrombocytopenia (HIT)&lt;br&gt;For patients on heparins, certain drugs can enhance bleeding tendency: acetylsalicylic acid (ASA) and other antiplatelet agents (e.g. clopidogrel, ticagrelor), and nonsteroidal anti-inflammatory drugs (NSAIDs) (particularly ketorolac). This is particularly relevant for patients with intrathecal catheters for analgesia where low molecular weight heparin (LMWH) or unfractionated heparin(UFH ) must NOT be used in conjunction with antiplatelet agents.&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Caution – Management of heparins with spinal punctures:&lt;/strong&gt;&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Time Before Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Use of anticoagulant in Patients with Indwelling Neuraxial Catheter&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Time After Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Laboratory Tests&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Unfractionated Heparin (UFH) - for prophylaxis, less than 15,000 IU/day&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;4 to 6 hours&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Acceptable&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1 hour&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Platelets during treatment for greater than 3 days&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Low Molecular Weight Heparin (LMWH) - for prophylaxis&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;12 hours&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;For single daily dosing –&amp;nbsp;catheter acceptable&lt;/p&gt;&lt;p&gt;(remove catheter 12 hours prior to next dose of LMWH, and subsequent dose should be greater than 4 hours after removal)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;For Twice daily dosing –&amp;nbsp;Do not maintain catheter&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;First postoperative dose at least 12 hours after neuraxial puncture and at least 4 hours after removal&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Subsequent dose at least 24 hours after the first dose&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Platelets during treatment for greater than 3 days&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Prophylaxis options for Neurological conditions&lt;/strong&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Type of Neurological Condition&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Intermittent Device (Sequential Compression Device) Only&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Pharmacoprophylaxis Only&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Sequential Compression Device &amp;amp; Pharmacoprophylaxis&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Intracerebral Hemorrhage (ICH)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Less than or equal to &amp;nbsp;48 hours after ictus or ICH and prior to CT/MRI growth cessation&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;MOBILE IN BED and greater than or equal to 48 hours after CT/MRI confirmation of growth cessation of ICH&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;IMMOBILE and greater than or equal to 48 hours after confirmation of growth cessation of ICH&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Post-Operative Neurosurgery&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Less than or equal to 24 hours post-operatively&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;NON-VENTILATED AND MOBILE IN BED greater than 24 hours post-operatively and LOW risk for venous thromboembolism (VTE)&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;VENTILATED OR IMMOBILE greater than 24 hours post-operatively and HIGH risk for VTE:&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Brain malignancy&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Elderly&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Prolonged surgery&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Pre-op or Post-op paresis&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Spinal Cord Injury&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Less than or equal to 12 hours prior to planned surgery until 24 hour post-operatively&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;MOBILE IN BED and greater than 24 hours post-operatively&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;IMMOBILE and greater than 24 hours postoperatively&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Complete vs. Incomplete&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Stroke&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Less than or equal to 24 hours of stroke irrespective of tPA therapy&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Hemorrhagic transformation post-tPA&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; High risk for hemorrhagic transformation post-tPA&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;MOBILE IN BED and greater than 24 hours after stroke&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;IMMOBILE and greater than 24 hours after stroke&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; LARGE strokes, particularly in Diabetics&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Subarachnoid Hemorrhage&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Unsecured aneurysm&lt;/p&gt;&lt;p&gt;Secured aneurysm with high risk of ICH&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;MOBILE IN BED and secured aneurysm without ongoing high risk of ICH&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;IMMOBILE IN BED and secured aneurysm without ongoing high risk of ICH&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Traumatic Brain Injury (TBI)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Less than or equal to 24 hours following TBI&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;MOBILE IN BED and greater than 24 hours following TBI and CT/MRI confirmed stability of contusions/subdural hemorrhage (SDH)/ICH/Epidural hemorrhages&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;IMMOBILE IN BED and greater than 24 hours following TBI and CT/MRI confirmed stability of contusions/SDH/ICH/Epidural hemorrhages&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&lt;strong&gt;Tumours of the Brain&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Un-resected hemorrhagic brain tumours including metastases from thyroid, renal cell, melanoma, choriocarcinoma&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;MOBILE IN BED and un-resected non-hemorrhagic tumours of the brain&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;IMMOBILE IN BED and un-resected non-hemorrhagic tumour of the brain&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;*** Mechanical prophylaxis should be considered for all patients as a standard.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk of Bleeding Contraindications&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;When bleeding risk decreases, pharmacologic thromboprophylaxis should be substituted for or added to mechanical thromboprophylaxis&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&lt;img alt=&quot;&quot; src=&quot;https://ahsckm.ca/ckm/document?cid=1175.123.43&quot; style=&quot;height:301px; margin-bottom:0px; margin-left:0px; margin-right:0px; margin-top:0px; width:500px&quot;&gt;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;Mechanical AND pharmacological prophylaxis is recommended&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;img alt=&quot;&quot; src=&quot;https://ahsckm.ca/ckm/document?cid=1175.123.43&quot; style=&quot;height:301px; margin-bottom:0px; margin-left:0px; margin-right:0px; margin-top:0px; width:500px&quot;&gt;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;Consider an additional therapy.&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Until discontinued&lt;/p&gt;&lt;p&gt;Action: Apply&lt;/p&gt;&lt;p&gt;Additional instructions: Remove while ambulating&lt;/p&gt;&lt;p&gt;&lt;em&gt;Recommended for highest risk patients as additional therapy&lt;/em&gt;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High/Very High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk Extended&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;Consider for patients with major hemiparetic stroke or spinal cord injury, for up to 12 weeks.&amp;nbsp;&lt;br&gt;Consider ordering antiembolism stockings or sequential compression device for highest risk patients.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk Extended&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk Extended&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;&amp;nbsp;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;br&gt;&amp;nbsp;&lt;img alt=&quot;&quot; src=&quot;https://ahsckm.ca/ckm/document?cid=1175.123.43&quot; style=&quot;height:301px; margin-bottom:0px; margin-left:0px; margin-right:0px; margin-top:0px; width:500px&quot;&gt;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk Extended&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk Extended&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk Extended&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin injection (adult);4500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;Adjust for weight less than 40 kg;&lt;/p&gt;&lt;p&gt;4,500 Units, subcutaneous, daily, at bedtime, Continue until discharge&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; 5000 unit/0.5 mL injection (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute)&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;5,000 Units, subcutaneous, every 12 hours, Continue until discharge&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Repeating&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;To monitor platelet count for heparin-induced thrombocytopenia (HIT) in heparin-exposed patients with risk of HIT greater than 1%.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;Avoid intramuscular (IM) injections while receiving anticoagulant therapy.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication&apos;]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication #1&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;Hold VTE prophylaxis if platelets 50 x 10^9 /L or less.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication #1&apos;]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="VTE Prophylaxis - Clinical Neurosurgery Adult">    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Clinical Decision Support">      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>    </Item>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Treatment Options (single select)">      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="High Risk of Bleeding Contraindications">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="PC Sequential Compression Device Order" max="1" path="/items" name="Sequential Compression Device; Apply, Until discontinued. For patients with a high risk of bleeding, use SCDs at least until the initial risk of bleeding decreases"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="PC AntiEmbolism Stockings Order" max="1" path="/items" name="AntiEmbolism Stockings; Bilateral, Until discontinued"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Low Risk">        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; No mechanical or pharmacological prophylaxis required"/>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Moderate Risk">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection (adult); subcutaneous, daily, at bedtime"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>          </Item>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        </Item>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="High/Very High Risk">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin injection">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis Patient">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>          </Item>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection (adult); subcutaneous, daily, at bedtime"/>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        </Item>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Additional Therapy">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="PC Sequential Compression Device Order" max="1" path="/items" name="Sequential Compression Device"/>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        </Item>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #3"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Very High Risk Extended">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin injection">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection (adult); subcutaneous, daily, at bedtime"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>          </Item>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        </Item>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Renal Dysfunction Dosing">        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection (adult);4500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5000 unit/0.5 mL injection (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute)"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>      </Item>    </Item>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Routine">      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential Order" max="1" path="/items" name="CBC, No Differential; Once, To provide baseline platelet count for patients receiving heparin"/>    </Item>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Repeating">      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential Order" max="1" path="/items" name="CBC, No Differential; Every 3 days, for 5 occurrences"/>    </Item>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8e8fff02-2546-4d47-871c-04a80a00bab8" concept_name="PC Activity Order" max="1" path="/items" name="Activity; Until discontinued, Early ambulation"/>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication"/>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication #1"/>    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health practioner(MRHP); Notify to reassess prophylaxis, if platelets 100 x 10^9 /L or less."/>  </definition>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">    <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.booleanorderquestion.v1">    <digest id="MD5-CAM-1.0.1">56B5A2F2979B94F83C97E66B46679692</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.quantityorderquestion.v1">    <digest id="MD5-CAM-1.0.1">22AFA84E6D7935A3623EDFA7C2EB6D65</digest>  </integrity_checks></template>